Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02216812 · ClinicalTrials.gov registry record · NA

Does Vitamin C Reduce Finger Stiffness After Distal Radius Fractures?

A NA study, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
134
Enrollment target

NCT02216812: Completed NA study, sponsored by Massachusetts General Hospital.

NCT02216812 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 134 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02216812, a NA study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
134 participants
Enrollment target

Study Summary

The reported prevalence of disproportionate pain and disability among patients recovering from a fracture of the distal radius varies widely. Literature reports numbers between 1% and 37%, perhaps in part because it is poorly defined, known by so many different names, subjective, and unverifiable. The investigators are interested in the effect of vitamin C after distal radius fractures on objective measurement of finger motion, patient reported outcome measures, and pain intensity, instead of the previously used, subjective and imprecise criteria for complex regional pain syndrome. Patients presenting to the Hand and Orthopaedic Trauma Services of MGH with a distal radius fracture will be asked to participate in this clinical trial. Patient will be randomly assigned to take either placebo or vitamin C 500 mg until full finger motion is attained as regarded by the treating physician at follow-up or for 6 weeks. The investigators hypothesize no difference in finger stiffness at 6 weeks measured by distance to palmar crease of the index through little finger between patients taking vitamin C or placebo after a distal radius fracture. Additionally, the investigators assess finger stiffness by range of motion and stiffness of the thumb, and difference in PROMIS upper extremity function and pain score both measured at six months.

Primary Outcome

To establish the distance to palmar crease, we asked patients to make a fist and determine the distance from nail tip to palmar crease for each individual digit using a ruler. We defined total distance to palmar crease as the sum of the values for the index, long, ring, and small fingers.

Interventions

  • DRUG 500 mg vitamin c, 1 pill per day for 6 weeks
  • DRUG 1 placebo pill for 6 weeks

Trial Details

FieldValue
Enrollment Target 134 participants
Start Date 2014-08
Est. Completion 2017-12-22
Phase NA
Massachusetts General Hospital

2,032 total trials

What the finished NCT02216812 record still lists

NCT02216812 is an interventional study that assigns participants to a tested intervention. The registered 134 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).

The record links to 0 conditions, and to 2 interventions - of which 500 mg vitamin c, 1 pill per day for 6 weeks is the first listed.

NCT02216812 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02216812 about?

NCT02216812 is a clinical study titled "Does Vitamin C Reduce Finger Stiffness After Distal Radius Fractures?". The reported prevalence of disproportionate pain and disability among patients recovering from a fracture of the distal radius varies widely. Literature reports numbers between 1% and 37%, perhaps in part because it is poorly defined, known by so many different names, subjective, and unverifiable. ...

What is the current status of trial NCT02216812?

This trial is currently completed. It is a NA study. The enrollment target is 134 participants. The study started on 2014-08. Estimated completion is 2017-12-22.

What interventions are being tested in trial NCT02216812?

The interventions under investigation include: 500 mg vitamin c, 1 pill per day for 6 weeks (DRUG), 1 placebo pill for 6 weeks (DRUG).

Who is sponsoring clinical trial NCT02216812?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02216812's enrollment target sits among peer trials

134 728th of 2000 higher than 1,272 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02469662 · 134 participants · NA

    Clinical Outcomes Study of the Nexel Total Elbow

  • NCT03110822 · 134 participants · Phase 1

    A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients

  • NCT04678648 · 134 participants · Phase 1

    A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

  • NCT05264857 · 134 participants · NA

    Decision Aid and Thyroid Nodules Management

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02216812, the US trial registry maintained by the National Library of Medicine. NCT02216812 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.